Snowden Capital Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,245
Closed -$11.5K 1273
2024
Q3
$11.5K Sell
10,245
-1,800
-15% -$2.02K ﹤0.01% 1211
2024
Q2
$13.1K Sell
12,045
-8,400
-41% -$9.16K ﹤0.01% 1181
2024
Q1
$26K Hold
20,445
﹤0.01% 1163
2023
Q4
$28.4K Sell
20,445
-1,054
-5% -$1.47K ﹤0.01% 1106
2023
Q3
$30.1K Sell
21,499
-1,200
-5% -$1.68K ﹤0.01% 1046
2023
Q2
$41.8K Buy
22,699
+200
+0.9% +$368 ﹤0.01% 1158
2023
Q1
$54.7K Sell
22,499
-6,605
-23% -$16.1K ﹤0.01% 1125
2022
Q4
$41.6K Sell
29,104
-2,600
-8% -$3.72K ﹤0.01% 1111
2022
Q3
$70K Sell
31,704
-1,350
-4% -$2.98K ﹤0.01% 1083
2022
Q2
$68K Sell
33,054
-3,000
-8% -$6.17K ﹤0.01% 1086
2022
Q1
$104K Buy
36,054
+6,405
+22% +$18.5K ﹤0.01% 993
2021
Q4
$95K Sell
29,649
-1,500
-5% -$4.81K ﹤0.01% 859
2021
Q3
$110K Sell
31,149
-300
-1% -$1.06K 0.01% 856
2021
Q2
$99.7K Sell
31,449
-400
-1% -$1.27K 0.01% 862
2021
Q1
$110K Buy
31,849
+850
+3% +$2.92K 0.01% 785
2020
Q4
$78.1K Buy
30,999
+1,600
+5% +$4.03K 0.01% 663
2020
Q3
$62K Buy
29,399
+1,600
+6% +$3.38K 0.01% 567
2020
Q2
$62.3K Buy
27,799
+4,349
+19% +$9.74K 0.01% 543
2020
Q1
$59.3K Buy
23,450
+3,800
+19% +$9.61K 0.01% 511
2019
Q4
$51.7K Sell
19,650
-409
-2% -$1.08K ﹤0.01% 577
2019
Q3
$72.2K Buy
20,059
+2,000
+11% +$7.2K 0.01% 505
2019
Q2
$60.9K Buy
18,059
+1,650
+10% +$5.56K 0.01% 503
2019
Q1
$44.8K Buy
16,409
+2,600
+19% +$7.1K ﹤0.01% 490
2018
Q4
$38.4K Buy
13,809
+3,700
+37% +$10.3K 0.01% 461
2018
Q3
$41.6K Buy
+10,109
New +$41.6K ﹤0.01% 487